MEETINGS - Understanding Validation of Manufacturing and Quality System Software and Process Validation for the Medical Industry (Netherlands) November 197:
This article was originally published in Clinica
IBC will hold a conference on Understanding Validation of Manufacturing & Quality System Software and Process Validation for the Medical Industry in Amsterdam on November 10-11. Topics to be discussed include the new FDA guidance on software validation, requirements specification and test plans, EN46000 quality management system requirements for process validation, and validation as part of a total quality assurance system. Contact IBC in the UK for more details. Tel: +44 171 453 2711.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.